News Drug price controversies hit pharma's reputation Patient groups slam pharma over drug costs in latest survey.
News Valeant's Siliq approved but suicidal thoughts warning will ... But drug will have boxed warning over suicidal ideation.
News Despite Trump price concerns, JP Morgan event anticipates M&... 2017 could be a bumper year for M&A - but Trump's price control threats dominate
News Valeant exec and Philidor chief charged with multi-million d... Two charged with massive deception and fraud - but Valeant escapes censure so far
News Valeant could sell gastro drug unit to Takeda Valeant may sell Salix and other units to pay off debts.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
